Lexeo Therapeutics (LXEO) Stock Snapshot: 2026 Market Overview & Key Stats
Lexeo Therapeutics (LXEO) shares rise 4.55% to $3.02, spotlighting its gene‑therapy focus and market cap of $221.6 M, plus latest 200‑day average.
- LEXEO THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read